Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Rating of “Moderate Buy” by Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has been given an average recommendation of “Moderate Buy” by the twelve research firms that are presently covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $10.50.

A number of brokerages recently issued reports on AVAH. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective for the company in a report on Friday, March 20th. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Barclays decreased their price objective on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a report on Monday, May 18th. Royal Bank Of Canada boosted their price objective on shares of Aveanna Healthcare from $9.00 to $10.00 and gave the company a “sector perform” rating in a report on Friday, May 15th. Finally, Truist Financial boosted their price objective on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a report on Wednesday.

Aveanna Healthcare Trading Down 4.4%

Shares of AVAH stock opened at $7.33 on Friday. Aveanna Healthcare has a 12-month low of $3.73 and a 12-month high of $10.32. The company has a market capitalization of $1.60 billion, a P/E ratio of 6.21, a P/E/G ratio of 0.91 and a beta of 1.93. The firm has a 50-day moving average price of $6.75 and a 200 day moving average price of $7.85. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The company had revenue of $647.92 million for the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. Aveanna Healthcare’s revenue was up 15.9% compared to the same quarter last year. Research analysts forecast that Aveanna Healthcare will post 0.56 earnings per share for the current fiscal year.

Insider Transactions at Aveanna Healthcare

In related news, insider Patrick A. Cunningham sold 125,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $7.59, for a total transaction of $948,750.00. Following the completion of the transaction, the insider owned 212,755 shares in the company, valued at approximately $1,614,810.45. The trade was a 37.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 5.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after buying an additional 2,400 shares during the period. Quantbot Technologies LP acquired a new position in shares of Aveanna Healthcare in the second quarter valued at approximately $43,000. Summit Securities Group LLC acquired a new position in shares of Aveanna Healthcare in the first quarter valued at approximately $53,000. Oxford Asset Management LLP acquired a new position in shares of Aveanna Healthcare in the second quarter valued at approximately $64,000. Finally, Bayesian Capital Management LP acquired a new position in shares of Aveanna Healthcare in the second quarter valued at approximately $85,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.